Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)

The use of noninsulin antihyperglycaemic drugs in the hospital setting has not yet been fully described. This observational study compared the efficacy and safety of the standard basal-bolus insulin regimen versus a dipeptidyl peptidase-4 inhibitor (linagliptin) plus basal insulin in medicine depart...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Belmonte, Luis M., Gómez-Doblas, Juan J., Millán-Gómez, Mercedes, López-Carmona, María D., Guijarro-Merino, Ricardo, Carrasco-Chinchilla, Fernando, de Teresa-Galván, Eduardo, Jiménez-Navarro, Manuel, Bernal-López, M. Rosa, Gómez-Huelgas, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162816/
https://www.ncbi.nlm.nih.gov/pubmed/30208631
http://dx.doi.org/10.3390/jcm7090271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162816/
https://www.ncbi.nlm.nih.gov/pubmed/30208631
http://dx.doi.org/10.3390/jcm7090271

Ejemplares similares